FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
This article was originally published in The Tan Sheet
Executive Summary
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
You may also be interested in...
OTC Acne Treatment Labels Should Add Sensitivity Test Direction – FDA
OTC topical acne drug product manufacturers have an option to add label directions for sensitivity testing for new users of their products, “to reduce the risk of serious hypersensitivity reactions,” the FDA says.
OTC Acne Treatment Labels Should Add Sensitivity Test Direction – FDA
OTC topical acne drug product manufacturers have an option to add label directions for sensitivity testing for new users of their products, “to reduce the risk of serious hypersensitivity reactions,” the FDA says.
OTC Firms Should Improve Monograph Compliance, Registration – CDER
CDER recommends the OTC industry ensure product innovations comply with monographs or have FDA approval prior to marketing. Umbrella-branding and facility registration rank high for the drug center in 2013.